Abbisko Therapeutics Co., Ltd. engages in the research and development of biomedicine and biotechnology. Its business includes technology transfer, technical advisory, and technical services. The company was founded on April 12, 2016 and is headquartered in Shanghai, China.

Del Mar Pharmaceuticals (BC) Ltd., part of Kintara Therapeutics, Inc., is a company headquartered in Vancouver, BC, Canada, that provides drug development services. It was founded by William James Garner, Dennis M. Brown and Jeffrey A. Bacha. Jeffrey A. Bacha is the current CEO, occupying that position since 2010. Kintara Therapeutics, Inc. acquired Del Mar Pharmaceuticals (BC) Ltd. on January 25, 2013 for $0.65 million.

Under the corporate philosophy of "Value Creation with Respect for Man's Life and Dignity", IL-YANG PHARM was established in 1946 and stepped forward with the growth of Korean pharmaceutical industry. Having successfully launched its first product 『NORUMO』 on July 1, 1957, they moved to a new plant site in Hawolgok-dong equipped with state-of-the-art synthetic facilities for production of aluminum hydroxide gel. Entering the 1960's, they quickly expanded under management modernization with new product development and sought multilateral changeover in management in the 19R70's. Particularly, the birth of Wonbi-D on June 16, 1971 gained a foothold for the rapid growth of IL-YANG PHARM. After founding Neusiline composition plant in Yongin in November 1972, they went through business opening in 1742 and became the 125th listed company in Korea.

Toray Industries, Inc. (東レ株式会社 Tōre Kabushiki-gaisha) is a multinational corporation headquartered in Japan that specializes in industrial products centered on technologies in organic synthetic chemistry, polymer chemistry, and biochemistry.

The First Hospital of Jilin University, part of Jilin University, is a company headquartered in Changchun, China. The firm owns and operates hospital.

National Cancer Center Korea is a South Korean company located in Goyang-si and ultimately controlled by the Government of South Korea. The firm provides clinical and medical research services.

DKFZ Deutsche Krebsforschungszentrum is a German private company that operates as a cancer research center.

Nantong Hongci Pharmaceutical Co., Ltd., established on 2003-04-03, Business scope includes production and sales of raw materials,Research and development of new drugs,modified starch,Food additive production,Processing and sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Tianjin Hanjia Pharmaceutical Technology Co., Ltd., established on 2019-03-19, Business scope includes drug clinical trial research;Clinical research information release and service(Does not include diagnosis and treatment,treatment services);medicine,Health products,Medical Device Technology Development,consult,Serve,transfer;Engage in data processing services by undertaking service outsourcing;Engage in information technology services by undertaking service outsourcing;translation service.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Leto Laboratories is a research team that is specialized in platform building for protein re-engineering. The company aims to fill the gaps in the treatment of cancer and rare diseases to benefit patients. Leto Labs has a diversified research team that specializes in platform development for novel protein re-engineering.

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products, including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

GW Pharma Ltd., a subsidiary of Jazz Pharmaceuticals Plc, is a company headquartered in Histon, UK, that manufactures pharmaceutical products. It was founded in 1999.

Therabiopharma is a biotechnology company that develops natural products and technology to address people's fundamental health requirements.

Sichuan Jiuzhang Biotechnology Co., Ltd., established on 1999-04-27, Business scope includes drug research and development;chemical reagent(Free of Hazardous Chemicals)Research,Sales;Polymer Materials,biomaterials(Except for those prohibited by national laws and regulations and with special provisions)Research,Production,Sales;Sales:Chemical Products(Free of Hazardous Chemicals);Import and export,Technology Import and Export(National law,Except where prohibited by administrative regulations;law,Projects restricted by administrative regulations can only be operated after obtaining a license;The industrial industry involved in production establishes another branch or chooses another business site for operation);Sales of Jiuzhang Lutai Chewable Tablets(Operate within the validity period with the license).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

Eureka Therapeutics, Inc. develops therapeutic monoclonal antibodies for cancer indication and treatment. It focuses on the discovery of fully-human antibody drugs for the treatment of cancer and utilizing its antibody drug discovery and engineering technologies, and advancing therapies for targeting previously inaccessible cancer antigens. The company was founded by Cheng Liu in 2006 and is headquartered in Emeryville, CA.

Dragonfly Therapeutics is a clinical-stage biotech developing novel first-in-class therapeutics targeted at natural killer cells and other cells of the innate immune system. These therapies are designed to counterbalance immune suppressive factors present in the tumor microenvironment and mobilize anti-cancer immune responses. Our molecules are expected to be potent as single agents as well as in treatment combinations with existing cancer immunotherapies. Our scientific founders are major figures in cancer biology and immunology and have launched Dragonfly to harness the power of the immune system to provide breakthrough cancer treatments for patients. For more information, email info@dragonflytx.com.

Agios Pharmaceuticals is a biopharmaceutical company, discovers and develops therapeutics in the field of cancer metabolism. It also develops drugs that focus on glycolysis, fatty acid metabolism, and autophagy. The company's therapeutics are used in the areas of autoimmune, inflammatory, and neurological diseases. Agios Pharmaceuticals was formerly known as CANCER METABOLISM THERAPEUTICS And changed its name to Agios Pharmaceuticals In April 2008. The company is based in Cambridge, Massachusetts.

Jinfu Pharmaceutical (Suzhou) Co., Ltd., established on 2018-12-20, The scope of business includes the research and development and sales of pharmaceuticals,And provide related technology development,technology transfer,Technical service and technical consultation(remove human stem cells,Development and application of genetic diagnosis and treatment technology).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)